Choi, J., Park, J., Ko, S. (2026). Clinical candidate JNC-1043, importin ß inhibitor (first in class), to target incurable cancers, TNBC, and colon cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e15096